Menu

F.D.A. Approves Ozempic to Treat Kidney Disease

The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have both Type 2 diabetes and chronic kidney disease.

Type 2 diabetes is a leading cause of chronic kidney disease, which affects more than one in seven U.S. adults. The medication can lower the chance that patients with both conditions will undergo worsening kidney disease, kidney failure and death from cardiovascular issues.

Scroll to Top